ストックスクリーナーアプリを入手
7.19
1.27%
0.09
アフターアワーズ：
7.19
Lifecore Biomedical Inc (LFCR) 最新ニュース
Lifecore Biomedical Approves Key Proposals at Annual Meeting - TipRanks
Can Lifecore Biomedical Inc. stock weather global recessionMarket Sentiment Summary & Proven Capital Preservation Methods - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stock2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Is Lifecore Biomedical Inc. stock affected by interest rate hikesJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Can Lifecore Biomedical Inc. stock beat market expectations this quarterMarket Activity Summary & Technical Entry and Exit Alerts - newser.com
Why millennials buy Lifecore Biomedical Inc. (LDE) stockJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
When is the best time to exit Lifecore Biomedical Inc.2025 Technical Patterns & Weekly Return Optimization Plans - newser.com
Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionBond Market & Weekly Return Optimization Alerts - newser.com
Will Lifecore Biomedical Inc. (LDE) stock recover faster than industryTake Profit & Capital Efficiency Focused Ideas - newser.com
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index fundsJuly 2025 Selloffs & Technical Entry and Exit Alerts - newser.com
Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesJuly 2025 Momentum & Daily Profit Focused Screening - newser.com
Is Lifecore Biomedical Inc. forming a reversal patternJuly 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com
What catalysts could drive Lifecore Biomedical Inc. stock higher2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
What hedge fund moves indicate for Lifecore Biomedical Inc. (LDE) stockQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire
Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3 - Insider Monkey
Will Lifecore Biomedical Inc. outperform the marketPrice Action & Precise Trade Entry Recommendations - newser.com
Key metrics from Lifecore Biomedical Inc.’s quarterly data2025 Top Gainers & Community Verified Trade Signals - newser.com
Can Lifecore Biomedical Inc. stock surprise with earnings upsidePortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
Will Lifecore Biomedical Inc. (LDE) stock benefit from infrastructure billGold Moves & Short-Term Swing Trade Alerts - newser.com
Is it too late to sell Lifecore Biomedical Inc.Quarterly Profit Review & Safe Entry Trade Reports - newser.com
Lifecore signs agreement with leading global pharmaceutical company - TipRanks
Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product - Contract Pharma
Lifecore Biomedical Selects as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company - MarketScreener
What analysts say about Lifecore Biomedical Inc stockTrend Following Strategies & Outstanding Growth Portfolio - earlytimes.in
Lifecore (NASDAQ: LFCR) to transfer manufacturing; second agreement with same multinational - Stock Titan
Lifecore and PolyPeptide link for US peptide manufacturing - Yahoo Finance
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Real time pattern detection on Lifecore Biomedical Inc. stockGap Down & Free High Accuracy Swing Entry Alerts - newser.com
Lifecore, PolyPeptide Partner on Peptide Manufacturing Solution for U.S. Market - Contract Pharma
What sentiment indicators say about Lifecore Biomedical Inc. stockWeekly Investment Report & Smart Investment Allocation Insights - Fundação Cultural do Pará
Lifecore, PolyPeptide collab to offer peptide manufacturing solution - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire
Lifecore, PolyPeptide Partner on Peptide Manufacturing for U.S. Market - Contract Pharma
Lifecore Biomedical, Inc. and Polypeptide Laboratories, Inc. Announce Collaboration Intended to Offer End-To-End Peptide Manufacturing Solution for U.S. Market - MarketScreener
Lifecore and PolyPeptide partner on integrated peptide manufacturing By Investing.com - Investing.com Nigeria
Lifecore and PolyPeptide partner on integrated peptide manufacturing - Investing.com
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market - The Manila Times
Lifecore Biomedical and PolyPeptide Laboratories Announce Collaboration to Enhance Peptide-Based Pharmaceutical Development - Quiver Quantitative
Lifecore (NASDAQ: LFCR), PolyPeptide sign U.S. DS-to-DP peptide collaboration - Stock Titan
3.18%
1.86%
大文字化:
|
ボリューム (24 時間):